These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 21192804)
21. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment. Myers KV; Amend SR; Pienta KJ Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471 [TBL] [Abstract][Full Text] [Related]
22. MafB enhances efferocytosis in RAW264.7 macrophages by regulating Axl expression. Sato M; Shibata Y; Inoue S; Igarashi A; Tokairin Y; Yamauchi K; Kimura T; Nemoto T; Sato K; Nakano H; Abe S; Nishiwaki M; Kobayashi M; Yang S; Minegishi Y; Furuyama K; Kubota I Immunobiology; 2018 Jan; 223(1):94-100. PubMed ID: 29030012 [TBL] [Abstract][Full Text] [Related]
23. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation. Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554 [TBL] [Abstract][Full Text] [Related]
24. Ligand-dependent kinase activity of MERTK drives efferocytosis in human iPSC-derived macrophages. Wanke F; Gutbier S; Rümmelin A; Steinberg M; Hughes LD; Koenen M; Komuczki J; Regan-Komito D; Wagage S; Hesselmann J; Thoma R; Brugger D; Christopeit T; Wang H; Point F; Hallet R; Ghosh S; Rothlin CV; Patsch C; Geering B Cell Death Dis; 2021 May; 12(6):538. PubMed ID: 34035216 [TBL] [Abstract][Full Text] [Related]
25. DBA/2J Haplotype on Distal Chromosome 2 Reduces Mertk Expression, Restricts Efferocytosis, and Increases Susceptibility to Atherosclerosis. Kayashima Y; Makhanova N; Maeda N Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):e82-e91. PubMed ID: 28473436 [TBL] [Abstract][Full Text] [Related]
26. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma. Holtzhausen A; Harris W; Ubil E; Hunter DM; Zhao J; Zhang Y; Zhang D; Liu Q; Wang X; Graham DK; Frye SV; Earp HS Cancer Immunol Res; 2019 Oct; 7(10):1672-1686. PubMed ID: 31451482 [TBL] [Abstract][Full Text] [Related]
27. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228 [TBL] [Abstract][Full Text] [Related]
28. Schwann cells use TAM receptor-mediated phagocytosis in addition to autophagy to clear myelin in a mouse model of nerve injury. Brosius Lutz A; Chung WS; Sloan SA; Carson GA; Zhou L; Lovelett E; Posada S; Zuchero JB; Barres BA Proc Natl Acad Sci U S A; 2017 Sep; 114(38):E8072-E8080. PubMed ID: 28874532 [TBL] [Abstract][Full Text] [Related]
29. BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity. Bae SH; Kim JH; Park TH; Lee K; Lee BI; Jang H Exp Mol Med; 2022 Sep; 54(9):1450-1460. PubMed ID: 36056187 [TBL] [Abstract][Full Text] [Related]
30. Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage. Chang CF; Goods BA; Askenase MH; Hammond MD; Renfroe SC; Steinschneider AF; Landreneau MJ; Ai Y; Beatty HE; da Costa LHA; Mack M; Sheth KN; Greer DM; Huttner A; Coman D; Hyder F; Ghosh S; Rothlin CV; Love JC; Sansing LH J Clin Invest; 2018 Feb; 128(2):607-624. PubMed ID: 29251628 [TBL] [Abstract][Full Text] [Related]
31. Efferocytosis is restricted by axon guidance molecule EphA4 via ERK/Stat6/MERTK signaling following brain injury. Soliman E; Leonard J; Basso EKG; Gershenson I; Ju J; Mills J; de Jager C; Kaloss AM; Elhassanny M; Pereira D; Chen M; Wang X; Theus MH J Neuroinflammation; 2023 Nov; 20(1):256. PubMed ID: 37941008 [TBL] [Abstract][Full Text] [Related]
32. Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction. DeBerge M; Glinton K; Subramanian M; Wilsbacher LD; Rothlin CV; Tabas I; Thorp EB J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33529176 [TBL] [Abstract][Full Text] [Related]
33. Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase. Kimani SG; Kumar S; Davra V; Chang YJ; Kasikara C; Geng K; Tsou WI; Wang S; Hoque M; Boháč A; Lewis-Antes A; De Lorenzo MS; Kotenko SV; Birge RB Cell Commun Signal; 2016 Sep; 14(1):19. PubMed ID: 27595981 [TBL] [Abstract][Full Text] [Related]
34. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders. Gadiyar V; Patel G; Chen J; Vigil D; Ji N; Campbell V; Sharma K; Shi Y; Weiss MM; Birge RB; Davra V Front Immunol; 2023; 14():1135373. PubMed ID: 37545504 [TBL] [Abstract][Full Text] [Related]
35. Cell-Corpse Clearance after Lung Damage: The Essential Role of MerTK-mediated Alveolar Macrophage Efferocytosis. Haczku A Am J Respir Cell Mol Biol; 2024 Jun; 70(6):433-434. PubMed ID: 38502903 [No Abstract] [Full Text] [Related]
36. An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo. Subramanian M; Hayes CD; Thome JJ; Thorp E; Matsushima GK; Herz J; Farber DL; Liu K; Lakshmana M; Tabas I J Clin Invest; 2014 Mar; 124(3):1296-308. PubMed ID: 24509082 [TBL] [Abstract][Full Text] [Related]
37. Impaired cell death and mammary gland involution in the absence of Dock1 and Rac1 signaling. Bagci H; Laurin M; Huber J; Muller WJ; Côté JF Cell Death Dis; 2014 Aug; 5(8):e1375. PubMed ID: 25118935 [TBL] [Abstract][Full Text] [Related]
38. Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis. Waterborg CEJ; Koenders MI; van Lent PLEM; van der Kraan PM; van de Loo FAJ PLoS One; 2018; 13(10):e0205902. PubMed ID: 30335822 [TBL] [Abstract][Full Text] [Related]
39. p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis. Yallowitz AR; Alexandrova EM; Talos F; Xu S; Marchenko ND; Moll UM Cell Death Differ; 2014 Apr; 21(4):645-54. PubMed ID: 24440910 [TBL] [Abstract][Full Text] [Related]
40. Tyro3, Axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment. Zhou L; Matsushima GK Int Rev Cell Mol Biol; 2021; 361():165-210. PubMed ID: 34074493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]